Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 2 |
2022 | 1 |
2023 | 1 |
2024 | 2 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Effect of MYC and PARP Inhibitors in Ovarian Cancer Using an In Vitro Model.
Anticancer Res. 2024 May;44(5):1817-1827. doi: 10.21873/anticanres.16983.
Anticancer Res. 2024.
PMID: 38677725
In Silico and In Vitro Mapping of Receptor-Type Protein Tyrosine Phosphatase Receptor Type D in Health and Disease: Implications for Asprosin Signalling in Endometrial Cancer and Neuroblastoma.
Orton S, Karkia R, Mustafov D, Gharanei S, Braoudaki M, Filipe A, Panfilov S, Saravi S, Khan N, Kyrou I, Karteris E, Chatterjee J, Randeva HS.
Orton S, et al. Among authors: saravi s.
Cancers (Basel). 2024 Jan 30;16(3):582. doi: 10.3390/cancers16030582.
Cancers (Basel). 2024.
PMID: 38339334
Free PMC article.
Item in Clipboard
Identification of RAD51 foci in cancer-associated circulating cells of patients with high-grade serous ovarian cancer: association with treatment outcomes.
Alizzi Z, Saravi S, Khalique S, McDonald T, Karteris E, Hall M.
Alizzi Z, et al. Among authors: saravi s.
Int J Gynecol Cancer. 2023 Sep 4;33(9):1427-1433. doi: 10.1136/ijgc-2023-004483.
Int J Gynecol Cancer. 2023.
PMID: 37541687
Free PMC article.
Item in Clipboard
Host cell entry mediators implicated in the cellular tropism of SARS‑CoV‑2, the pathophysiology of COVID‑19 and the identification of microRNAs that can modulate the expression of these mediators (Review).
Katopodis P, Randeva HS, Spandidos DA, Saravi S, Kyrou I, Karteris E.
Katopodis P, et al. Among authors: saravi s.
Int J Mol Med. 2022 Feb;49(2):20. doi: 10.3892/ijmm.2021.5075. Epub 2021 Dec 22.
Int J Mol Med. 2022.
PMID: 34935057
Free PMC article.
Review.
Item in Clipboard
Preclinical Studies on the Effect of Rucaparib in Ovarian Cancer: Impact of BRCA2 Status.
Saravi S, Alizzi Z, Tosi S, Hall M, Karteris E.
Saravi S, et al.
Cells. 2021 Sep 15;10(9):2434. doi: 10.3390/cells10092434.
Cells. 2021.
PMID: 34572083
Free PMC article.
Item in Clipboard
H2A Histone Family Member X (H2AX) Is Upregulated in Ovarian Cancer and Demonstrates Utility as a Prognostic Biomarker in Terms of Overall Survival.
Saravi S, Katsuta E, Jeyaneethi J, Amin HA, Kaspar M, Takabe K, Pados G, Drenos F, Hall M, Karteris E.
Saravi S, et al.
J Clin Med. 2020 Sep 2;9(9):2844. doi: 10.3390/jcm9092844.
J Clin Med. 2020.
PMID: 32887437
Free PMC article.
Item in Clipboard
Cite
Cite